This investor likes Vanguard FTSE right now

In an appearance on BNN Bloomberg Market Call on April 2, RN Croft Financial Group portfolio manager Richard Orrell highlighted the Vanguard FTSE Developed ex North America High Dividend Yield Index ETF as a way to broaden exposure beyond the U.S. while adding a more defensive dividend component.

Orrell said the fund fits with his effort to reduce heavy U.S. concentration and gain broader exposure to international developed markets. He said his thinking has been shaped in part by research into “lost decades” and the role global and emerging markets can play when leadership shifts away from the U.S.

“This fund has done well, and dividends tend to be a pretty good factor,” Orrell said, adding that he sees the ETF as a defensive way to participate in G7 and other developed markets outside North America.

He said the appeal is not necessarily to abandon U.S. exposure, but to complement it with international dividend-paying companies that could help diversify returns if market leadership broadens.

 

-30-

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

16 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

16 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

16 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

16 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

16 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

17 hours ago